Auxilium Pharma Slips To Loss In Q4 - Quick Facts

(RTTNews) - Auxilium Pharmaceuticals Inc. (AUXL) said that its fourth-quarter net loss was $23.9 million or $0.48 per share, compared to net income of $90.5 million or $1.83 per share in the year ago quarter.

But, non-GAAP net income for the fourth quarter was $13.4 million or $0.27 per share up from $10.6 million or $0.21 per share in the same quarter last year.

Net revenues for the quarter were $125.9 million, down from $172.5 million in the year ago quarter.

Non-GAAP net revenue for the prior year quarter was $80.5 million. It excluded the amount in the Non-GAAP net revenue of previously received and deferred up-front and milestone payments from Pfizer Inc. that it was required to recognize on a GAAP basis as revenue in the fourth quarter of 2012 as a consequence of the mutual termination of our collaboration agreement with Pfizer.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.22 per share and revenues of $111.83 million for the quarter. Analysts' estimates typically exclude special items.

For the twelve months ending December 31, 2014, the company expects non-GAAP net income to be in the range of $45 million to $50 million, and Global net revenues of $450 million to $490 million. Analysts project annual revenues of $488.94 million.